David Chubak is one of the financial world's youngest influencers. In his former role at Citi, David led a business that spans across global markets and serves more than 100 million customers, with 2,600 branches and 65,000 employees. With an eye to the future and an understanding of the past, he adheres to a philosophy that puts customer well-being first. In this most recent position, David consolidated the financial institution's global retail bank and consumer lending businesses and launched a digital banking strategy to ensure the bank meets the needs of the ever-evolving customer.

Billy Mawasha has been CEO of Kolobe Nala Investment Company (KNI) since April 2019. KNI is an investment holdings company with interests in mining, manufacturing, and energy.

Prior to KNI, Billy was Country Head – South Africa for Rio Tinto and Managing Director of Richard Bay Minerals. He previously held leadership, operational and technical roles at Anglo American (Kumba Iron Ore), AngloGold Ashanti and De Beers. His career has given him deep exposure to mining operations and projects across the Africa continent.

Billy is a Certified Director (IoDSA) and a Non-Executive Director of JSE listed Impala Platinum Holdings, Exxaro Resources and Metair Investments.

In 2017, Billy was selected as a Young Global Leader (YGL) of the World Economic Forum, and in March 2023, he was invited to join the World Economic Forum Global Future Council on Responsible Resource Use.

Billy graduated with an Engineering degree from the University of Cape Town and has completed executive development programmes at Harvard Kennedy School, Kellogg School of Management, London Business School and GIBS in South Africa.

Professor Billy Wai-Lung Ng is an Assistant Professor at the School of Pharmacy at The Chinese University of Hong Kong (CUHK), where he leads the Laboratory of Chemical Biology & Drug Discovery. He has successfully used cutting-edge technologies to develop therapeutic molecules for combating viral pandemics and aging-related diseases. Professor Ng and his international team were the first to discover that an approved HCV drug can be repurposed for the treatment of COVID-19. He is currently creating disruptive therapeutic molecules with the ultimate goal to eradicate cancers and neurodegenerative diseases. Professor Ng completed his post-doctoral training at Harvard Medical School and the University of Oxford after receiving his Ph.D. and B.Sc. in Chemistry from CUHK. He was also a Fulbright Scholar at Massachusetts Institute of Technology (MIT) during his graduate study. He has received numerous prestigious awards, including the Marie Curie Fellowship, Croucher Foundation Postdoctoral Fellowship, and Hong Kong PhD Fellowship.

Mark Stoffels is a senior global health tech executive. As Global Business Unit Leader and Senior Vice-President of Royal Philips’ Image Guided Therapy Systems, he is highly driven to improve global access to healthcare. Other roles at Royal Philips include Managing Director and Senior Vice-President Connected Care North America, Vice-President and General of Latin America, Country Manager Mexico, General Manager Health Systems Mexico and Strategic Marketing Director for Latin America. Stoffels is the author of "3 Billion Heart Beats", a novel on Buddhism which principles he works tirelessly to implement in his leadership style.